Indication

Uterine Corpus Cancer, Stage IB

1 clinical trial

1 product

1 drug

Clinical trial

A Pilot Phase II Trial of Radiation Therapy "Sandwiched" Between Paclitaxel and Carboplatin in Patients With High-Risk Endometrial Cancer After Standard Surgical Staging

Status: Terminated, Estimated PCD: 2019-10-01

Drug

Product